Provision of strategic advice to inform HTA and market access strategy
High-quality writing and analytical support to develop payer materials, including HTA submissions
Development of market access materials including GVDs, literature reviews and objection handlers to communicate the value of these novel therapies with payers and healthcare professionals
Medical communications to support with stakeholder education and launch across a number of different markets
The active role we play in conducting gene therapy research and participating in academic panel discussions, at conferences such as ISPOR, aids us in navigating the evolving gene therapy regulatory and reimbursement landscape.
We bring together the right people with expertise in gene therapy and experience with the relevant project type to meet the individual needs of each project.
We have offices in Europe, the US and the Asia-Pacific region which ensures we have a deep understanding of the different gene therapy landscapes to address region and country-specific challenges.
Our wide range of service offerings allow us to provide high-quality support throughout a gene therapy product’s lifecycle.
